Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Webb

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Pediatric Nephrology (Berlin, Germany)|December 5, 2012
Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndromeNicholas J A Webb, Shahnaz Shahinfar, Thomas G Wells, et al.
Clinical Kidney Journal|April 16, 2025
The prevalence of immunoglobulin A nephropathy in the European Union and the impact of the COVID-19 pandemic: an estimation approach utilizing the kidney biopsy frequencyJocelyn Buisker, Sigrid Behr, Nadine Janet Kubesch, et al.
BMC Health Services Research|February 16, 2012
Pan-Britain, mixed-methods study of multidisciplinary teams teaching parents to manage children's long-term kidney conditions at home: study protocolVeronica M Swallow, Davina Allen, Julian Williams, et al.
The British Journal of Radiology|July 1, 1996
Sonographic abnormalities of the thyroid gland following radiotherapy in survivors of childhood Hodgkin's diseaseJ C Healy, E A Shafford, R H Reznek, et al.
Kidney International|June 29, 2025
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR RegistrySherry Masoud, Katie Wong, David Pitcher, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 5, 2001
Psychological impact of receiving negative BRCA1 mutation test results in AshkenazimL C Friedman, J A Webb, C S Richards, et al.
Kidney International|January 4, 2026
The authors replyKatie Wong, Sherry Masoud, David Pitcher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 3, 2011
Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trialNicholas J A Webb, Chun Lam, Shahnaz Shahinfar, et al.
Kidney International|June 29, 2012
Losartan and enalapril are comparable in reducing proteinuria in childrenNicholas J A Webb, Shahnaz Shahinfar, Thomas G Wells, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2010
Randomized, double-blind, controlled study of losartan in children with proteinuriaNicholas J A Webb, Chun Lam, Tom Loeys, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Pediatric Nephrology (Berlin, Germany)|December 5, 2012
Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndromeNicholas J A Webb, Shahnaz Shahinfar, Thomas G Wells, et al.
Clinical Kidney Journal|April 16, 2025
The prevalence of immunoglobulin A nephropathy in the European Union and the impact of the COVID-19 pandemic: an estimation approach utilizing the kidney biopsy frequencyJocelyn Buisker, Sigrid Behr, Nadine Janet Kubesch, et al.
BMC Health Services Research|February 16, 2012
Pan-Britain, mixed-methods study of multidisciplinary teams teaching parents to manage children's long-term kidney conditions at home: study protocolVeronica M Swallow, Davina Allen, Julian Williams, et al.
The British Journal of Radiology|July 1, 1996
Sonographic abnormalities of the thyroid gland following radiotherapy in survivors of childhood Hodgkin's diseaseJ C Healy, E A Shafford, R H Reznek, et al.
Kidney International|June 29, 2025
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR RegistrySherry Masoud, Katie Wong, David Pitcher, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 5, 2001
Psychological impact of receiving negative BRCA1 mutation test results in AshkenazimL C Friedman, J A Webb, C S Richards, et al.
Kidney International|January 4, 2026
The authors replyKatie Wong, Sherry Masoud, David Pitcher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 3, 2011
Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trialNicholas J A Webb, Chun Lam, Shahnaz Shahinfar, et al.
Kidney International|June 29, 2012
Losartan and enalapril are comparable in reducing proteinuria in childrenNicholas J A Webb, Shahnaz Shahinfar, Thomas G Wells, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2010
Randomized, double-blind, controlled study of losartan in children with proteinuriaNicholas J A Webb, Chun Lam, Tom Loeys, et al.
Pageof 23